Promoter methylation might shift the balance of Galectin-3 & 12 expression in de novo adult acute myeloid leukemia patients
暂无分享,去创建一个
M. Ghoneim | M. Alshahrani | A. Belal | Heba I. Ghamry | M. Assem | A. A. Al-karmalawy | Mohammed A. S. Abourehab | Reem Nabil | Rady E. El-Araby | Mohamed M. Kamal | A. A. El Leithy | Mohammad Y Alshahrani | A. Al-karmalawy
[1] S. Farajnia,et al. Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated review , 2022, Molecular Biology Reports.
[2] O. Abdel-Wahab,et al. Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic , 2022, Genes & development.
[3] Somnath Ghosal,et al. DNA methylation: a saga of genome maintenance in hematological perspective , 2022, Human Cell.
[4] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[5] A. Jemal,et al. Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.
[6] A. Jemal,et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.
[7] William L. Redmond,et al. The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment , 2018, Oncoimmunology.
[8] M. Kloor,et al. Analyzing epigenetic control of galectin expression indicates silencing of galectin‐12 by promoter methylation in colorectal cancer , 2017, IUBMB life.
[9] Huiting Xue,et al. Galectin‐12 inhibits granulocytic differentiation of human NB4 promyelocytic leukemia cells while promoting lipogenesis , 2016, Journal of leukocyte biology.
[10] M. Assem,et al. Expression profiling of cancer-related galectins in acute myeloid leukemia , 2015, Tumor Biology.
[11] Yuping Sun,et al. Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts , 2015, Tumor Biology.
[12] T. Padera,et al. The lymph node microenvironment and its role in the progression of metastatic cancer. , 2015, Seminars in cell & developmental biology.
[13] L. Calvi,et al. Notch signaling in the malignant bone marrow microenvironment: implications for a niche‐based model of oncogenesis , 2015, Annals of the New York Academy of Sciences.
[14] A. Ebrahim,et al. Galectins in cancer: carcinogenesis, diagnosis and therapy. , 2014, Annals of translational medicine.
[15] J. Steyaert,et al. The metabolic cooperation between cells in solid cancer tumors. , 2014, Biochimica et biophysica acta.
[16] F. Grizzi,et al. Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness. , 2014, Annals of translational medicine.
[17] M. F. Troncoso,et al. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. , 2013, World journal of gastroenterology.
[18] J. Ro,et al. Galectin-7 is epigenetically-regulated tumor suppressor in gastric cancer , 2013, Oncotarget.
[19] S. Gutiérrez,et al. Epigenetic changes: a common theme in acute myelogenous leukemogenesis , 2013, Journal of Hematology & Oncology.
[20] A. Fusco,et al. DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy , 2013, Oncology letters.
[21] Chieh-Yu Liu,et al. Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia. , 2013, Blood.
[22] Jie He,et al. Report of incidence and mortality in China cancer registries, 2009. , 2013, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[23] A. Sonnenberg,et al. Epigenetic Regulation of Galectin-3 Expression by β1 Integrins Promotes Cell Adhesion and Migration* , 2012, The Journal of Biological Chemistry.
[24] Lu-Gang Yu,et al. Galectin-3--a jack-of-all-trades in cancer. , 2011, Cancer letters.
[25] J. Burger. Nurture versus nature: the microenvironment in chronic lymphocytic leukemia. , 2011, Hematology. American Society of Hematology. Education Program.
[26] K. Döhner,et al. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia , 2010, Leukemia.
[27] H. Ahmed,et al. Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer. , 2009, Translational oncology.
[28] D. Hsu,et al. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. , 2009, The Journal of investigative dermatology.
[29] F. Couch,et al. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. , 2008, Cancer research.
[30] G. Rabinovich,et al. Galectins: structure, function and therapeutic potential , 2008, Expert Reviews in Molecular Medicine.
[31] J. Herman,et al. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia , 2005, Annals of Hematology.
[32] B. Scheithauer,et al. Effects of DNA methylation on galectin-3 expression in pituitary tumors. , 2005, Cancer research.
[33] F. Poirier,et al. Effect of 5-azacytidine and galectin-1 on growth and differentiation of the human b lymphoma cell line bl36 , 2001, Cancer Cell International.
[34] H Kaltner,et al. Negative Regulation of Neuroblastoma Cell Growth by Carbohydrate-dependent Surface Binding of Galectin-1 and Functional Divergence from Galectin-3* , 2001, The Journal of Biological Chemistry.
[35] Jian Ni,et al. Cell Cycle Regulation by Galectin-12, a New Member of the Galectin Superfamily* , 2001, The Journal of Biological Chemistry.
[36] M. Toyota,et al. Methylation profiling in acute myeloid leukemia. , 2001, Blood.
[37] L. Yu,et al. This information is current as Macrophages Chemoattractant for Monocytes and Human Galectin-3 Is a Novel , 2000 .
[38] B. Quesnel,et al. Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression. , 1998, Blood.
[39] Colantuoni,et al. Activation of the galectin-1 (L-14-I) gene from nonexpressing differentiated cells by fusion with undifferentiated and tumorigenic cells. , 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[40] S. Stowell,et al. Galectins: An Ancient Family of Carbohydrate Binding Proteins with Modern Functions. , 2022, Methods in molecular biology.
[41] Ruiling Feng,et al. Overexpression of galectin2 (LGALS2) predicts a better prognosis in human breast cancer. , 2022, American journal of translational research.
[42] OUP accepted manuscript , 2021, Glycobiology.
[43] P. Ruvolo. Galectins as regulators of cell survival in the leukemia niche. , 2019, Advances in biological regulation.
[44] Hafiz Ahmed,et al. Examination of the regulation of galectin-3 expression in cancer. , 2015, Methods in molecular biology.
[45] R. Cummings,et al. Galectins -- Essentials of Glycobiology , 2009 .